Skip to main content

Published locations for Low-dose-rate brachytherapy remains feasible for prostate cancer patients with median lobe hyperplasia. 

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Low-dose-rate brachytherapy remains feasible for prostate cancer patients with median lobe hyperplasia. 

User login

  • Reset your password
  • /content/low-dose-rate-brachytherapy-remains-feasible-prostate-cancer-patients-median-lobe
  • /fedprac/article/242045/hepatocellular-carcinoma/low-dose-rate-brachytherapy-remains-feasible